Literature DB >> 16169618

Optimal risk management versus willingness to pay for BVDV control options.

J M Santarossa1, A W Stott, R W Humphry, G J Gunn.   

Abstract

Previous work has shown that the least-cost BVD-control option for cow-calf herds in Scotland was not necessarily the risk-minimising option. Thus, assessing BVDV prevention measures must account for risk reduction as well as decision-makers' attitude towards risks. We therefore describe a method to do this using a hypothetical example. Data for this analysis were generated using a simulation model of BVDV transmission in a typical Scottish cow-calf herd over a 10-year period. Herd infection/re-infection was adjusted to reflect the expected risk of infection/re-infection and the use of either biosecurity or vaccination strategies at various levels of effectiveness. The level of risk-free financial return that maximises farmers' utility of wealth was significantly affected by the assumed effectiveness of the control strategy. More importantly, it was observed that utility maximisation of wealth as a business objective is not an optimal solution in terms of animal welfare when dealing with a BVDV outbreak.

Entities:  

Mesh:

Year:  2005        PMID: 16169618     DOI: 10.1016/j.prevetmed.2005.08.019

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  3 in total

Review 1.  Optimal but unequitable prophylactic distribution of vaccine.

Authors:  Matt J Keeling; Andrew Shattock
Journal:  Epidemics       Date:  2012-03-07       Impact factor: 4.396

2.  Modelling the spread of bovine viral diarrhea virus (BVDV) in a beef cattle herd and its impact on herd productivity.

Authors:  Alix Damman; Anne-France Viet; Sandie Arnoux; Marie-Claude Guerrier-Chatellet; Etienne Petit; Pauline Ezanno
Journal:  Vet Res       Date:  2015-02-24       Impact factor: 3.683

3.  Exploring the role of voluntary disease schemes on UK farmer bio-security behaviours: Findings from the Norfolk-Suffolk Bovine Viral Diarrhoea control scheme.

Authors:  Lena Azbel-Jackson; Claire Heffernan; George Gunn; Joe Brownlie
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.